On September 28, 2026, BNP PARIBAS SA bought 204,800 shares of JUNSHI BIO (H shares) on the SEHK open market at an average of HKD 17.96 per share, involving about HKD 3.68 million, and it is an on-exchange active trade, i.e. a direct dealing in the secondary market.
Prior to the acquisition, BNP PARIBAS SA's long position in JUNSHI BIO was 23.34 million shares, representing 8.97%; following the acquisition, the holding changed to 23.55 million shares, with the long position ratio rising to 9.05%.